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Transcatheter aortic valve implantation (TAVI) has evolved as a routine procedure to treat selected high-risk patients
with severe aortic stenosis. The new J-Valve™ prosthesis is designed for antegrade transapical implantation, it is
characterized by a porcine aortic prosthesis attaching to a self-expandable Nitinol stent. The key feature of the
device are three U-shape anatomically oriented devices - “graspers” which could facilitate intuitive ‘self-positioning’
valve implantation. Hereby, we report a successful case of trans-apical TAVI in an elderly high-risk patient with
severe aortic stenosis using J-Valve™ system.
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Second generation TAVI deviceBackground
Transcatheter aortic valve implantation (TAVI) has been
recognized as a minimally invasive treatment option for
patients with inoperable or high-risk symptomatic aortic
stenosis [1]. The J-Valve™ system is a brand new second
generation TAVI device featured by a porcine aortic pros-
thesis attaching to a self-expandable Nitinol stent and
three U-shape anatomically oriented devices “graspers”
encircling around the stent. This unique design could fa-
cilitate intuitive “self-positioning” valve implantation and
provide both axial as well as radial fixation by embracing
the native valve leaflets. We performed the first-in-man
case of successfully TAVI operation for a high-risk patient
with severe aortic stenosis using the J-Valve™ system
through trans-apical approach.
Case report
An 80 years old female was referred to our hospital
due to severe aortic stenosis and recurrent episodes of* Correspondence: drguoyq@qq.com
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unless otherwise stated.decompensated left heart failure. She presented with a his-
tory of stroke 7 month ago with no obvious sequelae.
Transthoracic echocardiogram (TTE) confirmed a severe
aortic stenosis with a mean pressure gradient of 58 mmHg
and aortic valve opening area 0.6 cm2. Extra-cardiac arter-
ial disease involving carotid, intra-cranial and lower limb
arteries was confirmed through vascular ultrasound and
MRI angiogram. Preoperative CT angiogram revealed a
heavily calcified aortic valve with aortic annulus diameter
25 mm (derived from annulus perimeter). After inter-
disciplinary assessment, the patient was scheduled for
trans-apical aortic valve implantation because of a sig-
nificantly increased risk for conventional surgery. (Logistic
EuroSCORE = 28%). The informed consent was obtained
after discussing all available treatment options. Ethic com-
mittee of our hospital also approved this procedure.
The procedure was performed under general anesthesia
in a fully equipped hybrid operating room. Prior to skin
incision, a femoral ‘safety-net’ (percutaneous wires in the
femoral vessels) was placed and a readily primed CPB
machine was available in the room for immediate CPB
if required. Temporary pacemaker was placed in the right
ventricle through right internal jugular vein and then
the standard apical access was obtained. A cranial left-This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 2 The implantation process of J-Valve™ system (Part I).
Panel A-B: the delivery sheath was sent into the supra-annular plan
through transapical approach. Panel C-D: Three graspers (small black
arrow) were then totally released and pushed back gently into the
aortic sinuses, angiogram was performed to ensure the correct
position of the graspers.
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angulation of the fluoroscopic system which could provide
good visualization of each commissure of the aortic valve.
The apical puncture was done with a super-stiff guide-wire
placed in position. The standard apical aortic valvuloplasty
was performed using a straight 24-mm balloon under rapid
ventricular pacing (RVP). In parallel, a 27-mm J-Valve™
was crimped into the Ausper-AS delivery system (JC
Medical Inc., Florida, California, USA) (Figure 1). The
delivery system was bluntly inserted into the left ven-
tricle and advanced under fluoroscopic guidance into a
supra-annular position (Figure 2). In the next step, the
three ‘U-shape graspers’ were totally released and care was
taken to bring each grasper into the corresponding aortic
sinus by gently pulling back the delivery system, thereby
embracing the native leaflets (Figure 2). The correct pos-
ition was identified on both fluoroscopy as well as trans-
esophageal echocardiogram (TEE). Then the valve was
pulled back gently into the annular plan with the guidance
of the graspers and deployed without rapid ventricular
beating (Figure 3). After retrieval of the delivery system,
aortic root angiography revealed only trivial para-valvular
leakage with patent coronaries and good valve stent pos-
ition (Figure 3). TEE also confirmed a good valve position
with only trivial grade para-valvular leakage (Figure 4).
After wound closure, the patient was transferred to
the intensive care unit. Further postoperative course was
uneventful. At discharge, TTE revealed an excellent
valve function without any relevant incompetence and
obvious paravalvular leakage. The maximum and mean
transvalvular gradients were 18 and 11 mmHg measuredFigure 1 The J-Valve™ system. J-Valve™ is composed of a porcine
aortic valve attaching to a self-expandable nitinol stent with three
U-shape graspers encircling the valve stent.
Figure 3 The implantation process of J-Valve™ system (Part II).
Panel A-B: The valve was retrieved into the annular plan with the
help of the locking device. Panel C-D: The valve was then deployed
without rapid ventricular pacing, further angiogram confirmed good
position of the valve while without obvious paravalvular leakage.
Figure 4 Pre and post-operative TEE image of this patient.
Panel A: Preoperative TEE reveled a calcified aortic valve with severe
stenosis. Panel B: Both short and long axis view of TEE confirmed a
good valve position with only trivial grade para-valvular leakage.
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this patient remained in good health, TTE confirmed an
optimal valve position with no paravalvular leakage.
Discussion
TAVI has evolved as a routine procedure for high risk pa-
tient with severe aortic stenosis. Medtronic CoreValve™
and Edward SAPIEN™ are two classic TAVI systems which
have been widely used with accepted results [2,3]. How-
ever, these first-generation systems still have specific draw-
backs such as highly technique requirements for precise
valve positioning, relatively frequent requirement for
pace-maker implantation as well as high risk for more
than mild degree para-valvular leakage [2,3].
Next-generation transcatheter valves should overcome
the known limitations of the currently available TAVI.
In this case, we used the brand new J-Valve™ TAVI sys-
tem. Sharing the similarity with other second-generation
TAVI devices with anatomically oriented devices such as
Jena-Valve™ and Medtronic Engager Valve™ [4,5], this system
is characterized by a unique design U-shape graspers which
could be totally released before the valve implantation fa-
cilitating intuitive ‘self-positioning’ valve implantation.
This unique design could greatly simplify the implantation
process and lead to more consistent results, because the
operator does not need to actively judge for optimal valve
position. Meanwhile, through embracing the native valveleaflets through three U shape graspers, J-Valve™ system
has the advantage of achieving better anchoring, less risk
for coronary obstruction from native cusp calcification, as
well as less risk of conduction block (extra-axial fixation
and subsequent less radial expansion forces).
Also different from other second-generation TAVI de-
vices, U-Shape graspers of J-Valve™ system could increase
the interface between aortic valve leaflets and valve pros-
thesis which would provide more anchorage force (axial
fixation) after valve deployment. In addition, the unique
two stage releasing design of this system (graspers totally
release first and followed by the valve release) could also
largely facilitate accurate adjusting the position of the
graspers before valve deployment. Furthermore, compared
with single arm feeler device of Jena-valve™, this U-shape
grasper could also minimize the risk of native valve
perforation.
Conclusion
The new J-Valve™ prosthesis is a brand new second gen-
eration TAVI device. It is featured by three U-shape ana-
tomical orientated devices - “graspers” which could
largely facilitate intuitive ‘self-positioning’ valve implant-
ation. As shown in this case, this system provide a po-
tential valuable treatment option for high risk patients
with severe aortic stenosis.
Consent
Note: Written informed consent was obtained from the
patient for publication of this case report and any accom-
panying images. A copy of the written consent is available
for review by the Editor-in-Chief of this journal.
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